The evolution of multigene panel testing for hereditary cancers.

Area of Science:

• Oncology
• Genetics
• Preventive Medicine

Background:

• Family history evaluation is essential for identifying hereditary cancer risk.
• The American College of Obstetricians and Gynecologists (ACOG) recommends regular family history updates for all women.
• Abnormal findings necessitate further evaluation, including hereditary cancer testing.

Purpose of the Study:

• To emphasize the importance of family history in hereditary cancer risk assessment.
• To highlight the role of multigene panel testing in comprehensive genetic profiling.
• To discuss management strategies for patients with established hereditary cancer.

Main Methods:

• Review of current recommendations for family history evaluation.
• Discussion of multigene panel testing as a diagnostic tool.
• Outline of management options following hereditary cancer diagnosis.

Main Results:

• Family history evaluation is a critical first step in risk identification.
• Multigene panel testing offers broader risk assessment than single gene tests.
• Management includes surveillance, chemoprevention, and surgical options.

Conclusions:

• Integrating hereditary cancer risk assessment into clinical practice is vital.
• Workflow protocols can facilitate the implementation of risk assessment.
• Personalized management strategies improve outcomes for hereditary cancer patients.